» Articles » PMID: 30874883

Gene Variants, MRNA and NOD1/2 Protein Levels in Tunisian Childhood Asthma

Overview
Journal Lung
Specialty Pulmonary Medicine
Date 2019 Mar 16
PMID 30874883
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Asthma is a common respiratory childhood disease that results from an interaction between genetic, environmental and immunologic factors. The implication of nucleotide-binding and oligomerization domain 1 and 2 (NOD1/CARD4, NOD2/CARD15) was highlighted in many inflammatory diseases.

Methods: In this case-control study, we analyzed the association of three NOD2 polymorphisms and one NOD1 variant, in 338 Tunisian asthmatic children and 425 healthy Controls, using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. We also assessed NOD1 and NOD2 mRNA and protein levels by qRT-PCR and ELISA techniques.

Results: The homozygous AA genotype of rs2075820 was a risk factor for asthma (OR 2.39). The influence of the E266K variant in the presence of the heterozygous AG genotype was higher in male than female groups. The homozygous AA genotype was a risk factor associated with asthma, for patients aged between 6 and 18 years OR 2.39, IC95% (1.04-5.49) p < 0.01. The mRNA expression of NOD1, but not NOD2, was enhanced in asthma patients compared to Controls. We noted a significant difference between asthmatics and healthy controls in NOD1 protein expression (asthma patients : 31.18 ± 10.9 pg/ml, Controls: 20.10 ± 2.58 pg/ml; p < 0.001).

Conclusions: The NOD1 rs2075820 variant was associated with a higher childhood asthma risk and the NOD1 expression at mRNA and protein levels was significantly increased in asthma patients.

Citing Articles

NOD-like receptors in asthma.

Alvarez-Simon D, Ait Yahia S, de Nadai P, Audousset C, Chamaillard M, Gomperts Boneca I Front Immunol. 2022; 13:928886.

PMID: 36189256 PMC: 9515552. DOI: 10.3389/fimmu.2022.928886.


Nucleotide-Oligomerizing Domain-1 Activation Exaggerates Cigarette Smoke-Induced Chronic Obstructive Pulmonary-Like Disease in Mice.

Han G, Li M, Du J, Chen Y, Xu C Int J Chron Obstruct Pulmon Dis. 2021; 16:2605-2615.

PMID: 34556981 PMC: 8453445. DOI: 10.2147/COPD.S323616.

References
1.
Ege M, Strachan D, Cookson W, Moffatt M, Gut I, Lathrop M . Gene-environment interaction for childhood asthma and exposure to farming in Central Europe. J Allergy Clin Immunol. 2011; 127(1):138-44, 144.e1-4. DOI: 10.1016/j.jaci.2010.09.041. View

2.
Kvarnhammar A, Petterson T, Cardell L . NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists. Immunology. 2011; 134(3):314-25. PMC: 3209571. DOI: 10.1111/j.1365-2567.2011.03492.x. View

3.
Duan W, Mehta A, Magalhaes J, Ziegler S, Dong C, Philpott D . Innate signals from Nod2 block respiratory tolerance and program T(H)2-driven allergic inflammation. J Allergy Clin Immunol. 2010; 126(6):1284-93.e10. PMC: 3058679. DOI: 10.1016/j.jaci.2010.09.021. View

4.
Shin J, Kim S, Park Y . Role of NOD1-mediated signals in a mouse model of allergic rhinitis. Otolaryngol Head Neck Surg. 2012; 147(6):1020-6. DOI: 10.1177/0194599812461999. View

5.
Wong C, Leung T, Chu I, Dong J, Lam Y, Kei Lam C . Aberrant expression of regulatory cytokine IL-35 and pattern recognition receptor NOD2 in patients with allergic asthma. Inflammation. 2014; 38(1):348-60. DOI: 10.1007/s10753-014-0038-4. View